Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.
By T. Kanda, T. Fukusato, M. Matsuda, K. Toyoda, H. Oba, J. Kotoku, T. Haruyama, K. Kitajima, S. Furui. Radiology, 2015
853 citations recorded by the source corpus.
Subfields: Geochemistry and Petrology, Materials Chemistry, Nephrology
View Paper: https://www.semanticscholar.org/paper/1dfeee76e6c628fde76b0885ebf74582aea2f69e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- John M. Pauly
- Enhao Gong
- M. Wintermark
- Greg Zaharchuk
- Arvid Lundervold
- Justin P. Haldar
- Florian Knoll
Citations in the corpus
- Deep learning enables reduced gadolinium dose for contrast‐enhanced brain MRI (2018, background): “Studies have demonstrated increased signal intensity on the unenhanced T1weighted MR images in the dentate nucleus (DN) and globus pallidus (GP) that is correlated with previous GBCA exposure and the deposition is independent of renal function.(21) While initial reports focused on linear GBCAs, more”